1,459
Participants
Start Date
April 29, 2024
Primary Completion Date
July 29, 2024
Study Completion Date
March 18, 2025
RSVPreF3 OA investigational vaccine
1 dose of RSVPreF3 OA investigational vaccine is administered intramuscularly on Day 1.
GSK Investigational Site, Reiger Park
GSK Investigational Site, Sydney
GSK Investigational Site, Sydney
GSK Investigational Site, Johannesburg
GSK Investigational Site, Coffs Harbour
GSK Investigational Site, St Albans
GSK Investigational Site, Melbourne
GSK Investigational Site, Fortitude Valley
GSK Investigational Site, Tarragindi
GSK Investigational Site, Cape Town
GSK Investigational Site, Cape Town
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Berlin
GSK Investigational Site, Rochester
GSK Investigational Site, Silver Spring
GSK Investigational Site, Charlottesville
GSK Investigational Site, Orlando
GSK Investigational Site, Hialeah
GSK Investigational Site, North Miami
GSK Investigational Site, Knoxville
GSK Investigational Site, Lexington
GSK Investigational Site, Essen
GSK Investigational Site, Mainz
GSK Investigational Site, Witten
GSK Investigational Site, Weinheim
GSK Investigational Site, Oklahoma City
GSK Investigational Site, DeSoto
GSK Investigational Site, Phoenix
GSK Investigational Site, Glendale
GSK Investigational Site, Wallerfing
GSK Investigational Site, Walnut Creek
GSK Investigational Site, Oakland
GSK Investigational Site, Würzburg
GSK Investigational Site, Wenatchee
GSK Investigational Site, North Hollywood
GSK Investigational Site, New Westminster
GSK Investigational Site, Victoria
GSK Investigational Site, Truro
GSK Investigational Site, Greater Sudbury
GSK Investigational Site, Guelph
GSK Investigational Site, London-Ontario
GSK Investigational Site, Toronto
GSK Investigational Site, Québec
GSK Investigational Site, Québec
GSK Investigational Site, Québec
GSK Investigational Site, Saint-Charles-Borromée
GSK Investigational Site, Sherbrooke
GSK Investigational Site, Ibaraki
GSK Investigational Site, Kanagawa
GSK Investigational Site, Tokyo
GSK Investigational Site, Tokyo
Lead Sponsor
GlaxoSmithKline
INDUSTRY